Author:
Miyahara Koji,Nouso Kazuhiro,Morimoto Yuki,Kinugasa Hideaki,Kato Hironari,Yamamoto Naoki,Tsutsumi Koichiro,Kuwaki Kenji,Onishi Hideki,Ikeda Fusao,Nakamura Shinichiro,Shiraha Hidenori,Takaki Akinobu,Nakahara Taku,Miura Yoshiaki,Asada Hidehisa,Amano Maho,Nishimura Shin-Ichiro,Yamamoto Kazuhide
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference31 articles.
1. Global cancer statistics.;Jemal;CA Cancer J Clin,2011
2. Cancer statistics, 2013.;Siegel;CA Cancer J Clin,2013
3. EUROCARE-4: survival of cancer patients diagnosed in 1995-1999: results and commentary.;Sant;Eur J Cancer,2009
4. 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.;Burris;J Clin Oncol,1997
5. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial.;Reni;Lancet Oncol,2005
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献